About Cytoreason

Closing the data-insight gap since 2016

our story

The volume of human molecular data is growing exponentially, but our analytic capabilities are growing linearly, at best. Humans alone cannot process all this data. What’s needed is a technology capable of digesting, organizing and making sense of all data types and sources.

We founded CytoReason in 2016 to address this problem. Our computational disease models are designed to gather impossible amounts of data from countless indications and treatments. They tell you which genes are active, in which cells, within which pathways, and across which diseases, patients, and drugs.

You can then use these insights to prioritize new targets, find biomarkers, profile combinations and much much more. Ever-growing and ever-updating, CytoReason’s disease models simplify complex molecular mechanisms and illegible disease readouts, making them understandable to researchers of all levels, in any organization.

To date, five of the world’s top ten pharma companies use CytoReason’s technology to identify new opportunities, shorten trial phases, reduce development costs, and increase the likelihood of drug approval.

leadership

David Harel
Co-Founder & CEO
Prof. Shai Shen-Orr
Co-Founder & Chief Scientist
Prof. Yehuda Chowers, MD
Chief Medical Officer
Adir Katz
Chief Data Scientist
Elina Starosvetsky, PhD
Co-Founder & VP Biology
Yael Villa, PhD
Chief Operating Officer
Exclusion 1
Oshrat Kfir
VP Product Management
Exclusion 1
Ofek Levy
VP of Finance
Exclusion-2
Michal Katzir
VP HR
Exclusion-2
Yoav Aharoni
VP R&D

Science Advisory Board

JC Gutiérrez-Ramos
Exclusion 1
Tom Bumol
Exclusion 1
Fabian Theis
Chris Sander
Exclusion-2
Michael Vincent
Exclusion-2
John Tsang

Board of Directors

Exclusion-2
Shai Shen-Orr
Exclusion-2
David Harel
Exclusion-2
Todd Kesselman
Exclusion-2
Eyal Desheh
Exclusion-2
Jeremy Goldberg

THE CYTOREASON WAY

Bring your data to life

Skip to content